|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Design,synthesis,and characterization of a series of cytochrome P 450 3A-activated prodrugs useful for targeting phosph(on)ate-based drugs to the liver显示文摘 | Erion MD Reddy KR Boyer SH | 2004 | J Am Chem Soc2004，126，16： | 1 |
| 2 | Remofovir mesylate:a prodrug of PMEA with improved liver-targeting and safety in ratsmonkeys显示文摘 | Erion MD Colby Tj Reddy KR | 2004 | Antiviral Chem Chemother2004，15，： | 1 |
| 3 | Discovery of fructose-l, 6-bisphosphatase inhibitors for the treatment of type 2 diabetes 显示文摘 | van Poelje PD Dang Q Erion MD | 2007 | Curr Opin Drug Discov Devel2007，10，： | 1 |
| 4 | Structure-guided design of AMP mimics that inhibit fructose-l, 6-bisphosphatase with high affinity and specificity 显示文摘 | Erion MD Dang Q Reddy MR | 2007 | J Am Chem Soc2007，129，15： | 1 |
| 5 | Liver-targeted drug delivery using HepDirect prodrugs显示文摘 | Erion MD van Poelje PD Mackenna DA | 2005 | Pharmacol Exp Ther2005，312，2： | 1 |
| 6 | Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs ( HepDirect prodrugs) useful for targeting phosph (on)ate-based drugs to the liver显示文摘 | ERION MD REDDY KR BOYER SH | 2004 | J Am Chem Soc2004，126，16： | 1 |
| 7 | HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver显示文摘 | Erion MD Bullough DA Lin CC | 2006 | Curr Opin Investig Drugs2006，7，2： | 1 |
| 8 | Prodrugs of phosphates and phosphonates显示文摘 | HECKER S J ERION MD | 2008 | J Med Chem2008，51，8： | 1 |
| 9 | Liver-targeted drug delivery using HepDirect prodrugs显示文摘 | Erion MD van Poelje PD Mackenna DA | 2005 | J Pharmacol Exp Ther2005，312，2： | 1 |
| 10 | Design, synthesis, and characterization of a series of cytochrome P4503A-activated prodmgs(HepDirect prodrugs)useful for targeting phosph(on)atebased drugs to the liver显示文摘 | ERION MD REDDY KR BOYER SH | 2004 | J Am Chem Soc2004，126，16： | 1 |
| 11 | MB06322 ( CS-917 ) : A potent and selective inhibitor of fructose 1, 6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes显示文摘 | Erion MD van Poelje PD Dang Q | 2005 | Proc Natl Acoxl Sci USA2005，102，22： | 1 |
| 12 | Stereoselective synthesis of nucleoside monophosphate HepDirect prodrugs 显示文摘 | REDDY KR BOYER SH ERION MD | 2005 | Tetrahedron Lett2005，46，25： | 1 |
| 13 | Design, synthesis,and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) usefulfor targeting phosph(on)ate-based drugs to the liver显示文摘 | Erion MD Reddy KR Boyer SH | 2004 | JAm Chem Soc2004，126，16： | 1 |
| 14 | Design, synthesis, and characterization of a series of cytochrome P (450) 3A-activated prodrugs ( HepDirect prodrugs ) useful for targeting phosph (on)ate-based drugs to the liver 显示文摘 | Erion MD Reddy KR Boyer S | 2004 | J Am Chem Soc2004，126，： | 1 |
| 15 | Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach显示文摘 | Reddy MR Erion MD | 2001 | Am Chem Soc2001，123，3： | 1 |
| 16 | Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach显示文摘 | Reddy MR Erion MD | 2001 | J Am Chem Soc2001，123，26： | 1 |
| 17 | Design, synthe- sis, and characterizati on of a series of cytochrome P( 450 ) 3A2 activated prodrugs ( HepDireet prodrugs ) useful for targeting phosphon ate- based drugs to the liver 显示文摘 | Erion MD Reddy KR Boyer S | 2004 | J Am Chem Soe2004，，16： | 1 |
| 18 | Livertargeted drug delivery using HepDirect prodrugs显示文摘 | Erion MD Van Poelje PD Mackenna DA | 2005 | J Pharmacol Exp Ther2005，312，2： | 1 |
| 19 | Design,synthesis,and characterization of a series of cytochrome P (450) 3A-activated prodrugs(HepDirect prodrugs)useful for targeting phosph(on)ate-based drugs to the liver显示文摘 | Erion MD Reddy KR Boyer SH | 2004 | J Am Chem Soc2004，126，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员